DLBCL Treatment Performance in EU5 and US
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
The DLBCL market is undergoing a period of change, and the relative performance of the various...
Posts about
Syndicated Studies (2)
DLBCL Market Overview
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Following the release of our latest ebook, this is the first blog post in this series focusing on...
New AplusA eBook Covers the DLBCL Market
AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Introducing the latest eBook in AplusA's Hemato-Oncology series
Primary vs Secondary Data
Tracking Studies, Syndicated Studies
A thorough and agile tracking study can aid marketers to envision emerging trends, consumer...
DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening
hemato-oncology, DLBCL market, Social Media Listening, Syndicated Studies, Oncology
Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...
Patient Insights from AplusA’s Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Multiple Myeloma Market Dynamics Revealed by AplusA Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Brand Performance Insights from AplusA's Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Key Insights from a Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
5 Benefits of Syndicated Research in the Hematology Oncology Market
Healthcare Industry, Market Research Industry, hemato-oncology, Syndicated Studies
In the rapidly evolving